semaglutide for pain linked to reduced arthritis knee in people with obesity, study finds Over 30 million Americans are

Description

Understanding the link between rapid alopecia weight loss caused by GLP-1 drugs and hair shedding.

launch expected in early 2026 This approval expands treatment options and marks a major milestone for GLP-1 therapies

Two new programs incorporate OPTA VIA ASCEND products for easy nutrition, with or without medications, and provide strategies support to help with weight maintenance High-protein products help preserve lean muscle mass during weight loss, addressing the accelerated muscle loss often associated with GLP-1 medications 1* Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTA VIA, today announced OPTAVIA ASCEND a new product l